Identification of ErbB-2 kinase domain motifs required for geldanamycin-induced degradation - PubMed (original) (raw)
. 2003 Jan 1;63(1):39-43.
Affiliations
- PMID: 12517775
Identification of ErbB-2 kinase domain motifs required for geldanamycin-induced degradation
Oleg Tikhomirov et al. Cancer Res. 2003.
Abstract
The ansamycin antibiotic geldanamycin (GA) induces the intracellular degradation of ErbB-2/neu. Degradation of ErbB-2 proceeds through cleavage(s) within the kinase domain, resulting in the formation of a 135 kDa ectodomain fragment and a fragment(s) of approximately 50 kDa containing the COOH-terminal region. On the basis of independent means of identification, two adjacent sequence motifs have been identified in ErbB-2 that are required for GA-induced degradation. These motifs encompass residues 776-783 and 784-786 within the NH(2)-terminal lobe of the ErbB-2 kinase domain. This is also a region in which the epidermal growth factor receptor and ErbB-2 kinase domains differ significantly in sequence. Although mutations in this region abrogate GA-induced ErbB-2 degradation, the tyrosine kinase activity of ErbB-2 is not disrupted. Interestingly, these ErbB-2 mutants are specifically resistant to GA-induced degradation but retain sensitivity to other drugs, such as staurospore and curcumin, which are also able to provoke ErbB-2 degradation.
Similar articles
- Geldanamycin induces ErbB-2 degradation by proteolytic fragmentation.
Tikhomirov O, Carpenter G. Tikhomirov O, et al. J Biol Chem. 2000 Aug 25;275(34):26625-31. doi: 10.1074/jbc.M003114200. J Biol Chem. 2000. PMID: 10862618 - Caspase-dependent cleavage of ErbB-2 by geldanamycin and staurosporin.
Tikhomirov O, Carpenter G. Tikhomirov O, et al. J Biol Chem. 2001 Sep 7;276(36):33675-80. doi: 10.1074/jbc.M101394200. Epub 2001 Jun 11. J Biol Chem. 2001. PMID: 11402024 - Surface charge and hydrophobicity determine ErbB2 binding to the Hsp90 chaperone complex.
Xu W, Yuan X, Xiang Z, Mimnaugh E, Marcu M, Neckers L. Xu W, et al. Nat Struct Mol Biol. 2005 Feb;12(2):120-6. doi: 10.1038/nsmb885. Epub 2005 Jan 9. Nat Struct Mol Biol. 2005. PMID: 15643424 - The ErbB/HER receptor protein-tyrosine kinases and cancer.
Roskoski R Jr. Roskoski R Jr. Biochem Biophys Res Commun. 2004 Jun 18;319(1):1-11. doi: 10.1016/j.bbrc.2004.04.150. Biochem Biophys Res Commun. 2004. PMID: 15158434 Review. - Chemical approaches to controlling intracellular protein degradation.
Schneekloth JS Jr, Crews CM. Schneekloth JS Jr, et al. Chembiochem. 2005 Jan;6(1):40-6. doi: 10.1002/cbic.200400274. Chembiochem. 2005. PMID: 15532104 Free PMC article. Review. No abstract available.
Cited by
- Proposal for a role of the Hsp90/Hsp70-based chaperone machinery in making triage decisions when proteins undergo oxidative and toxic damage.
Pratt WB, Morishima Y, Peng HM, Osawa Y. Pratt WB, et al. Exp Biol Med (Maywood). 2010 Mar;235(3):278-89. doi: 10.1258/ebm.2009.009250. Exp Biol Med (Maywood). 2010. PMID: 20404045 Free PMC article. Review. - Endocytic down-regulation of ErbB2 is stimulated by cleavage of its C-terminus.
Lerdrup M, Bruun S, Grandal MV, Roepstorff K, Kristensen MM, Hommelgaard AM, van Deurs B. Lerdrup M, et al. Mol Biol Cell. 2007 Sep;18(9):3656-66. doi: 10.1091/mbc.e07-01-0025. Epub 2007 Jul 11. Mol Biol Cell. 2007. PMID: 17626164 Free PMC article. - SORLA regulates endosomal trafficking and oncogenic fitness of HER2.
Pietilä M, Sahgal P, Peuhu E, Jäntti NZ, Paatero I, Närvä E, Al-Akhrass H, Lilja J, Georgiadou M, Andersen OM, Padzik A, Sihto H, Joensuu H, Blomqvist M, Saarinen I, Boström PJ, Taimen P, Ivaska J. Pietilä M, et al. Nat Commun. 2019 May 28;10(1):2340. doi: 10.1038/s41467-019-10275-0. Nat Commun. 2019. PMID: 31138794 Free PMC article. - The HSP90 inhibitor geldanamycin perturbs endosomal structure and drives recycling ErbB2 and transferrin to modified MVBs/lysosomal compartments.
Cortese K, Howes MT, Lundmark R, Tagliatti E, Bagnato P, Petrelli A, Bono M, McMahon HT, Parton RG, Tacchetti C. Cortese K, et al. Mol Biol Cell. 2013 Jan;24(2):129-44. doi: 10.1091/mbc.E12-04-0282. Epub 2012 Nov 14. Mol Biol Cell. 2013. PMID: 23154999 Free PMC article. - Akt shows variable sensitivity to an Hsp90 inhibitor depending on cell context.
Theodoraki MA, Kunjappu M, Sternberg DW, Caplan AJ. Theodoraki MA, et al. Exp Cell Res. 2007 Nov 1;313(18):3851-8. doi: 10.1016/j.yexcr.2007.06.022. Epub 2007 Jul 6. Exp Cell Res. 2007. PMID: 17643429 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous